Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Straumann Holding    STMN   CH0012280076

STRAUMANN HOLDING

(STMN)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
02/20/2020 02/21/2020 02/24/2020 02/25/2020 02/26/2020 Date
1039.5(c) 1044(c) 976.2(c) 944(c) 969 Last
84 103 64 058 106 077 72 600 75 257 Volume
+2.57% +0.43% -6.49% -3.30% +2.65% Change
More quotes
Financials (CHF)
Sales 2020 1 796 M
EBIT 2020 469 M
Net income 2020 380 M
Finance 2020 72,8 M
Yield 2020 0,74%
Sales 2021 2 041 M
EBIT 2021 550 M
Net income 2021 453 M
Finance 2021 334 M
Yield 2021 0,88%
P/E ratio 2020 39,3x
P/E ratio 2021 33,0x
EV / Sales2020 8,30x
EV / Sales2021 7,17x
Capitalization 14 977 M
More Financials
Company
Straumann Holding specializes in the design, manufacture and marketing of dental products and materials. Net sales break down by activity as follows: - sales of dental products (56.9%): implants, surgical instruments, diagnostic tools (distance indicators for implants, drilling guides, etc.),... 
More about the company
Surperformance© ratings of Straumann Holding
Trading Rating : Investor Rating :
More Ratings
Latest news on STRAUMANN HOLDING
02/18Straumann finishes 2019 with solid Q4, as full-year organic revenue climbs 17..
TE
02/18STRAUMANN HOLDING : Slide show results
CO
02/18STRAUMANN HOLDING : Annual results
CO
02/13STRAUMANN HOLDING : annual earnings release
02/11STRAUMANN GROUP TO PUBLISH FULL-YEAR : 30 CET on 18 February 2020
TE
02/03Mark Johnson joins Straumann's Executive Management as Head of Research, Deve..
TE
01/20Camila Finzi appointed Head of Straumann's fast-growing orthodontics business..
TE
2019Straumann Group strengthens emphasis on orthodontics and digital transformati..
TE
2019GLOBAL MARKETS LIVE : Mastercard, Alphabet, Pfizer, LVMH…
2019Nine-month revenue exceeds CHF 1bn (+16%) for the first time, as the Strauman..
TE
2019STRAUMANN HOLDING : Slide show Q3 results
CO
2019STRAUMANN HOLDING : 3rd quarter results
CO
2019INVITATION : Straumann Group 2019 Third-quarter sales report webcast
TE
2019Straumann Group and Modern Dental Group join forces to serve customers in Hon..
TE
2019Straumann Group announces two appointments to its Executive Management team
TE
More news
News in other languages on STRAUMANN HOLDING
02/18Aktien Schweiz Schluss: Defensive Werte bewahren SMI vor stärkerem Kursrückga..
02/18BOURSE ZURICH : le SMI finit en baisse, le luxe plombé par la Chine
02/18Straumann will Wachstumsstory mit neuen Produkten weiterschreiben
02/18Aktien Schweiz: Apple-Warnung sorgt für Ernüchterung - SMI gibt moderat nach
02/18Bourse Zurich: pertes stabilisées, Vifor et AMS voués aux gémonies
More news
Analyst Recommendations on STRAUMANN HOLDING
More recommendations
Stock Trading Strategies
STRAUMANN HOLDING - 2019
Good timing to anticipate a continuation of the trend
BUY
More Stock Trading Analysis
Sector news : Medical Prosthetics
02/25Mallinckrodt Nets Government Support for $1.6 Billion Opioid Deal -- 3rd Upda..
DJ
02/21Pharmaceutical companies develop system to better track counterfeit drugs
RE
02/20FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Fiscal Year Earnings, Revenue..
DJ
02/20SMITH & NEPHEW : +Nephew forecasts sales growth after best year since 2010
RE
02/18MEDTRONIC : Raises 2020 Guidance, Sets 4Q Outlook
DJ
More sector news : Medical Prosthetics
Chart STRAUMANN HOLDING
Duration : Period :
Straumann Holding Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends STRAUMANN HOLDING
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 969,94  CHF
Last Close Price 944,00  CHF
Spread / Highest target 21,8%
Spread / Average Target 2,75%
Spread / Lowest Target -37,9%
EPS Revisions
Managers
NameTitle
Guillaume Daniellot Chief Executive Officer
Gilbert Achermann Chairman
Gerhard Bauer Head-Research, Development & Operations
Peter Hackel Chief Financial Officer
Thomas Straumann Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
STRAUMANN HOLDING-0.67%15 347
MEDTRONIC PLC-1.85%145 516
ABBOTT LABORATORIES-2.57%143 067
STRYKER CORPORATION-1.73%77 279
BECTON, DICKINSON AND COMPANY-9.76%66 554
BAXTER INTERNATIONAL INC.4.03%44 413